BioengineeringbioRxiv
Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates
F. P. Pons-Faudoa, A. Sizovs, K. A. Shelton…·A. Grattoni
This study evaluates a long-acting tenofovir alafenamide nanofluidic implant in nonhuman primates, showing partial protection against SHIV infection.
DOI 10.1002/adtp.202000163